Validation of a commercially available SARS-CoV-2 serological immunoassay

OBJECTIVES: To validate the diagnostic accuracy of a Euroimmun SARS-CoV-2 IgG and IgA immunoassay for COVID-19. METHODS: In this unmatched (1:2) case-control validation study, we used sera of 181 laboratory-confirmed SARS-CoV-2 cases and 326 controls collected before SARS-CoV-2 emergence. Diagnostic...

詳細記述

保存先:
書誌詳細
出版年:Clin Microbiol Infect
主要な著者: Meyer, B., Torriani, G., Yerly, S., Mazza, L., Calame, A., Arm-Vernez, I., Zimmer, G., Agoritsas, T., Stirnemann, J., Spechbach, H., Guessous, I., Stringhini, S., Pugin, J., Roux-Lombard, P., Fontao, L., Siegrist, C.-A., Eckerle, I., Vuilleumier, N., Kaiser, L.
フォーマット: Artigo
言語:Inglês
出版事項: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2020
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7320699/
https://ncbi.nlm.nih.gov/pubmed/32603801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmi.2020.06.024
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料